| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 208652 | 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- | 0.0247898374452139 | 0.32208639 |
| NSC 266047 | 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) | 0.0247898374452139 | 0.46393033 |
| NSC 281613 | Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) | 0.0247898374452139 | -0.0019381039 |
| NSC 347217 | Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride | 0.0247898374452139 | 0.37739811 |
| NSC 349447 | Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) | 0.0247898374452139 | 0.13467594 |
| NSC 373355 | Saframycin R | 0.0247898374452139 | 0.30248261 |
| NSC 381811 | Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- | 0.0247898374452139 | 0.21086812 |
| NSC 48300 | ANTINEOPLASTIC-48300 | 0.0247898374452139 | 0.47229064 |
| NSC 602313 | Null | 0.0247898374452139 | 0.42046139 |
| NSC 609815 | 2-Benzoylaminobenzamide, N-thiazol-2-yl- | 0.0247898374452139 | 0.19794146 |